Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,682.2
29.2 (1.10%)

 

  • STI Straits Times Index
    2,682.2
    29.2 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,167.5
    794.4 (3.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,316.6
    163.8 (5.20%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,702.0
    395.5 (1.77%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 834.2M
  • Value: 529.8M
  • Rise: 228
  • Fall: 65
  • Unch: 515

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.121+0.006
Rex Intl0.186+0.006
Medtecs Intl0.590+0.090
LionGold0.002-
Yoma Strategic0.320+0.005
Synagie0.197+0.006
MDR0.001-
AnAn Intl0.070+0.006
ThaiBev0.715+0.020
KOP0.069+0.008

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TOPGLOV TOP GLOVE CORPORATION BHD
Quotes 15 Minutes Delayed. Updated at 06 Jul 2020 14:00
Last (MYR): 20.580 Change: +2.120 High: 20.640 Remarks:
Change (%): +11.48 Low: 18.540
Open 18.540 Yesterday's Close 18.460
Buy Price 22.140 Sell Price 19.560
Buy Volume ('00) 1 Sell Volume ('00) 1
Cumulative Volume ('00) 216,978 Cumulative Value 428,286,704
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.13536 Trailing EPS (MYR) e 0.24096 NAV (MYR) b 1.2526
PE a 152.039 Trailing PE f 85.407 Price / NAV b 16.4298
Dividend (MYR) d 0.071263 Cash In Hand (MYR) g 0.1291 Issued & Paid-up Shares c 2,694,050,000
Dividend Yield (%) d 0.346 Price / Cash In Hand g 159.411 Treasury Shares h 662,000
Beta - 75 Daysi 1.321 R-Squared - 75 Days(%)i 21.42 Market Cap (M) 55,443.549
Beta - 500 Daysi 0.906 R-Squared - 500 Days (%)i 9.30 Enterprise Value (M) 56,479.806
Piotroski F Score 4 Exchange Code 7113 Par Value ( MYR ) 0.50000
52 Weeks Volatility (%) 54.79 6-Month VWAP 9.713 Free Float (%) 53.1
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FBM EMAS / FBM EMAS SHARIAH / FBM KLCI / FBM TOP 100
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Jun 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TOPGLOV Bursa 55,443.549 152.039 85.407 16.4298 0.346
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 1,816.044 125.058 94.385 16.0502 0.190
Medical Specialties Bursa 31,640.783 136.542 102.953 17.6818 0.152
Index BM HEALTH CARE Bursa 11,591.751 106.910 108.044 5.6387 0.391
FBM EMAS Bursa 5,126.879 20.642 24.200 1.3317 3.174
FBM EMAS SHARIAH Bursa 4,787.237 33.638 40.951 1.6792 2.319
FBM KLCI Bursa 33,869.166 19.202 21.941 1.7317 3.209
FBM TOP 100 Bursa 13,334.683 20.287 23.216 1.5600 3.075
Local Peer HARTA Bursa 57,392.822 132.003 132.004 22.5867 -
Local Peer SUPERMX Bursa 13,456.617 109.305 95.419 10.8327 -
Local Peer LKL Bursa 270.144 - - - -
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), KDL MEDICAL (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), PW MEDTECH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UG Healthcare (SGX), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), Biolidics (SGX), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESONANCE HEALTH LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), RESPIRI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), NEUROTROPE INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), LIFE HEALTHCARE (HKEx), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), OPTISCAN IMAGING (ASX), DIGIRAD CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), OBALON THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+5.680
+38.12 %
10 Days 0.100+5.180
+34.29 %
20 Days 0.100+4.200
+26.25 %
Medium Term Return 3 Months 0.100+14.180
+223.12 %
6 Months 0.100+15.910
+342.83 %
1 Year 0.140+15.740
+328.10 %
Long Term Return 2 Years 0.225+14.530
+243.88 %
3 Years 0.380+17.770
+645.91 %
5 Years 0.735+18.806
+1101.52 %
Annualised Return Annualised --
+64.42 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.210 - 18.480 Change From 1 Year Low +16.370 % Change From 1 Year Low (%) +388.84
Change From 1 Year High +2.100 % Change From 1 Year High (%) +11.36
2 Years Range 4.210 - 18.480 Change From 2 Years Low +16.370 % Change From 2 Years Low (%) +388.84
Change From 2 Years High +2.100 % Change From 2 Years High (%) +11.36
5 Years Range 1.734 - 18.480 Change From 5 Years Low +18.846 % Change From 5 Years Low (%) +1087.06
Change From 5 Years High +2.100 % Change From 5 Years High (%) +11.36
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1991 with only one factory and three production lines, Top Glove has since grown by leaps and bounds to become the world's largest rubber glove manufacturer. It was listed on the Malaysian bourse, Bursa Saham Kuala Lumpur on 27 March 2001. In a short span of slightly more than a year, on 16 May 2002, Top Glove Corporation Berhad's listing was successfully promoted from the Second Board to the Main Market of the Kuala Lumpur Stock Exchange. Top Glove has a shareholder fund of RM1.09 billion or USD358 million with an annual turnover of about RM2.08 billion or USD682 million as at financial year ended 31 August 2010. It is also one of the component stocks of the FTSE Bursa Malaysia ("FBM") Mid 70 Index, FBM Top 100 Index and FBM Emas Index with a market capitalization of RM3.28 billion as at 30 March 2011.

IPO Performance

Listing Date 27 Mar 2001 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 7.51 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.700 First Day Close (MYR) 0.495 First Week Close (MYR) 0.398
Current vs IPO Price (%) +662.22 First Day Gain (%) -81.67 First Week Gain (%) -85.26

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Aug 2019 Part 1(2.73 MB)
Part 2(2.39 MB)
Part 3(2.33 MB)
Part 4(2.51 MB)
Annual Report 2018 Aug 2018 Part 1(2.52 MB)
Part 2(1.90 MB)
Part 3(0.17 MB)
Part 4(0.62 MB)
Annual Report 2017 Aug 2017 Part 1(0.59 MB)
Part 2(3.00 MB)
Part 3(1.65 MB)
Annual Report 2016 Aug 2016 Part 1(2.73 MB)
Part 2(2.70 MB)
Part 3(2.62 MB)
Annual Report 2015 Aug 2015 Part 1(2.78 MB)
Part 2(0.83 MB)
Annual Report 2014 Aug 2014 Part 1(2.59 MB)
Part 2(1.36 MB)
Annual Report 2013 Aug 2013 Part 1(2.76 MB)
Part 2(1.78 MB)
Annual Report 2012 Aug 2012 Part 1(2.78 MB)
Annual Report 2011 Aug 2011 Part 1(2.86 MB)
Annual Report 2010 Aug 2010 Part 1(2.97 MB)
Part 2(3.08 MB)
Annual Report 2009 Aug 2009 Part 1(1.95 MB)
Part 2(2.87 MB)
Annual Report 2008 Aug 2008 Part 1(3.46 MB)
Annual Report 2007 Aug 2007 Part 1(2.84 MB)
Part 2(1.69 MB)
Annual Report 2006 Aug 2006 Part 1(1.89 MB)
Annual Report 2005 Aug 2005 Part 1(0.49 MB)
Part 2(0.18 MB)
Part 3(1.92 MB)
Part 4(1.57 MB)
Part 5(0.65 MB)
Part 6(0.26 MB)
Part 7(0.32 MB)
Part 8(1.36 MB)
Part 9(1.38 MB)
Part 10(1.01 MB)
Annual Report 2004 Aug 2004 Part 1(1.35 MB)
Part 2(0.80 MB)
Part 3(0.50 MB)
Part 4(2.43 MB)
Part 5(1.35 MB)
Part 6(0.95 MB)
Part 7(1.41 MB)
Annual Report 2003 Aug 2003 Part 1(0.54 MB)
Part 2(0.50 MB)
Part 3(3.55 MB)
Part 4(0.53 MB)
Part 5(0.78 MB)
Part 6(0.86 MB)
Annual Report 2002 Aug 2002 Part 1(0.69 MB)
Part 2(0.51 MB)
Part 3(0.76 MB)
Part 4(0.41 MB)
Annual Report 2001 Aug 2001 Part 1(0.93 MB)
Part 2(0.31 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jul 2020 17.800 18.480 17.300 18.460 17,357,900 17.9368
02 Jul 2020 17.160 17.940 17.120 17.500 21,954,400 17.5371
01 Jul 2020 16.220 17.180 16.120 17.140 22,711,400 16.7879
30 Jun 2020 16.000 16.420 15.800 16.100 20,157,700 16.1564
29 Jun 2020 14.900 15.820 14.800 15.700 24,412,800 15.3237
26 Jun 2020 15.520 15.520 14.800 14.900 14,238,200 15.0422
25 Jun 2020 15.400 15.640 15.320 15.500 16,642,200 15.5238
24 Jun 2020 15.700 15.700 15.440 15.600 8,858,300 15.6054
23 Jun 2020 15.700 15.740 15.200 15.640 16,019,000 15.5354
22 Jun 2020 15.300 15.800 15.200 15.600 16,194,200 15.5656
19 Jun 2020 14.300 15.400 14.020 15.400 36,915,100 15.0123
18 Jun 2020 15.600 15.820 14.440 14.700 41,685,300 14.8448
17 Jun 2020 16.340 16.380 15.520 15.700 15,664,000 15.7824
16 Jun 2020 16.000 16.300 15.520 15.960 20,709,600 15.8663
15 Jun 2020 17.200 17.260 15.000 15.200 38,662,600 15.7920
12 Jun 2020 15.580 17.280 15.500 16.900 19,459,200 17.4643
11 Jun 2020 17.220 18.000 16.600 16.700 50,899,700 17.0649
10 Jun 2020 17.000 17.200 16.720 17.080 17,149,900 16.9770
09 Jun 2020 16.720 17.240 16.500 17.000 25,980,500 16.8177
05 Jun 2020 16.180 16.740 16.000 16.380 30,476,300 16.3758
04 Jun 2020 14.320 15.500 13.520 15.440 42,848,800 14.7301
03 Jun 2020 14.760 14.760 10.580 14.700 41,756,700 13.5133
Summary
Current 2 Weeks
(22 Jun 2020 to 03 Jul 2020)
15.300 18.480 14.800 18.460 178,546,100 -
Previous 2 Weeks
(05 Jun 2020 to 19 Jun 2020)
16.180 18.480 14.800 15.400 297,602,200 -
4 Weeks from
(04 May 2020 to 04 Jun 2020)
7.260 18.480 7.080 15.440 469,490,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.